|
|
|||||||||
GCs are used commonly for the treatment of various inflammatory and autoimmune diseases. Although potent and generally effective, they are not without risks for producing serious adverse effects, especially when used in high doses for prolonged periods of time. Thus, the clinician must balance the therapeutic effects of GCs with their risks for adverse effects; using the lowest possible effective GC doses as well as maximizing other therapeutic modalities are means by which this goal can be achieved. Early recognition and appropriate management are other methods to minimize GC-induced adverse effects. Maximization of therapy, early recognition, and appropriate management of adverse effects can minimize the potential severe complications of GC therapy.
Special Considerations in the Use of Glucocorticoids in Children
Joseph D. Spahn MD1
Alan K. Kamada PharmD2
1 Divisions of Clinical Pharmacology and Allergy Immunology, Department of Pediatrics
2 Division of Clinical Pharmacology, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO.
This article has been cited by other articles:
![]() |
M. E. George, V. Sharma, J. Jacobson, S. Simon, and A. J. Nopper Adverse Effects of Systemic Glucocorticosteroid Therapy in Infants With Hemangiomas Arch Dermatol, August 1, 2004; 140(8): 963 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bereket and T. Erdogan Oral Bisphosphonate Therapy for Vitamin D Intoxication of the Infant Pediatrics, April 1, 2003; 111(4): 899 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M STANBURY and E. M GRAHAM Systemic corticosteroid therapy---side effects and their management Br. J. Ophthalmol., June 1, 1998; 82(6): 704 - 708. [Full Text] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | CME | ARCHIVE | SEARCH | TABLE OF CONTENTS |